Concepedia
Statistics
Publications
1
Citations
17
H-Index
Active since
2023
Affiliations
Qilu University of Technology(Current)
Qingmei Zheng is an author at Qilu University of Technology.
Publications per year
2023–2023
Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer
Yingying Yang, Qingmei Zheng, Xinmei Wang et al. · Investigational New Drugs · 2023 · 17 citations · Full text
1–1 of 1